These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 17040593)
1. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer. Jebreel A; Mistry D; Loke D; Dunn G; Hough V; Oliver K; Stafford N; Greenman J J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593 [TBL] [Abstract][Full Text] [Related]
2. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma. Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523 [TBL] [Abstract][Full Text] [Related]
3. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921 [TBL] [Abstract][Full Text] [Related]
4. Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck. Lathers DM; Young MR Cytokine; 2004 Mar; 25(5):220-8. PubMed ID: 15036248 [TBL] [Abstract][Full Text] [Related]
5. Expression of IL-18 in patients with head and neck squamous cell carcinoma. Riedel F; Adam S; Feick P; Haas S; Götte K; Hörmann K; Int J Mol Med; 2004 Feb; 13(2):267-72. PubMed ID: 14719133 [TBL] [Abstract][Full Text] [Related]
6. Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production. O'Hara RJ; Greenman J; MacDonald AW; Gaskell KM; Topping KP; Duthie GS; Kerin MJ; Lee PW; Monson JR Clin Cancer Res; 1998 Aug; 4(8):1943-8. PubMed ID: 9717823 [TBL] [Abstract][Full Text] [Related]
7. Modulation of Th1 and Th2 cytokine profiles and their association with advanced head and neck squamous cell carcinoma. Sparano A; Lathers DM; Achille N; Petruzzelli GJ; Young MR Otolaryngol Head Neck Surg; 2004 Nov; 131(5):573-6. PubMed ID: 15523428 [TBL] [Abstract][Full Text] [Related]
8. Defining cancer cachexia in head and neck squamous cell carcinoma. Richey LM; George JR; Couch ME; Kanapkey BK; Yin X; Cannon T; Stewart PW; Weissler MC; Shores CG Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6561-7. PubMed ID: 18006755 [TBL] [Abstract][Full Text] [Related]
9. Different plasma levels of interleukins and chemokines: comparison between children and adults with AIDS in China. Jin CZ; Zhao Y; Zhang FJ; Yao HP; Wu LJ; Zhao HX; Wei HS; Wu NP Chin Med J (Engl); 2009 Mar; 122(5):530-5. PubMed ID: 19323903 [TBL] [Abstract][Full Text] [Related]
10. The phenotypic changes in tumour infiltrating lymphocytes and tumour cells following intra-arterial infusion of interleukin-2 in patients with squamous cell carcinoma. Salter J; Maclennan KA; Moore J; Dadian G; Riches PG; Gore ME J Pathol; 1995 Jun; 176(2):167-73. PubMed ID: 7636627 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma. Nakano H; Kishida T; Asada H; Shin-Ya M; Shinomiya T; Imanishi J; Shimada T; Nakai S; Takeuchi M; Hisa Y; Mazda O J Gene Med; 2006 Jan; 8(1):90-9. PubMed ID: 16097036 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Duffy SA; Taylor JM; Terrell JE; Islam M; Li Y; Fowler KE; Wolf GT; Teknos TN Cancer; 2008 Aug; 113(4):750-7. PubMed ID: 18536030 [TBL] [Abstract][Full Text] [Related]
13. Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma. Bergmann C; Strauss L; Zeidler R; Lang S; Whiteside TL Cancer Res; 2007 Sep; 67(18):8865-73. PubMed ID: 17875728 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity. Jacob SE; Nassiri M; Kerdel FA; Vincek V Mediators Inflamm; 2003 Oct; 12(5):309-13. PubMed ID: 14760939 [TBL] [Abstract][Full Text] [Related]
15. Increased sensitivity to bleomycin in upper aerodigestive tract mucosa of head and neck squamous cell carcinoma patients. Jin C; Jin Y; Wennerberg J; Rosenquist B; Mertens F Mutat Res; 2008 Mar; 652(1):30-7. PubMed ID: 18243046 [TBL] [Abstract][Full Text] [Related]
16. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor. van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016 [TBL] [Abstract][Full Text] [Related]
17. [Postoperative Th1 and Th2 type cytokine changes in patients with esophageal squamous cell carcinoma and their clinical significance]. Wei YC; Hu FB; Shen Y; Xu LH; Lin LS Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1271-3. PubMed ID: 15567776 [TBL] [Abstract][Full Text] [Related]
18. [Clinical observation of the changes of serum helper T-lymphocytes (TH) cytokines in patients with HIV-infection and opportunistic infection]. Rao HP; Feng L; Li D; Bader A; Wu NP Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jan; 41(1):42-5. PubMed ID: 17484210 [TBL] [Abstract][Full Text] [Related]
19. Plasmatic cytokine network in patients with laryngeal carcinoma after surgical treatment. Pignataro L; Corsi MM; Sambataro G; Porcaro L; Tredici P; Broich G Anticancer Res; 2001; 21(5):3621-5. PubMed ID: 11848533 [TBL] [Abstract][Full Text] [Related]
20. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C. Kitaoka S; Shiota G; Kawasaki H Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]